Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 106, Issue 1, 216-223, July 1, 2005
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
Blood Segura et al. 106: 216

Supplemental Figures and Table for: Segura et al, Vol 106, Issue 1, 216-223

Files in this Data Supplement:

  • Table S1. Proteins identified in immature and mature exosomes (PDF, 369 KB) - B indicates B cells; HEK, human embryonic kidney 293T cells; IEC, intestinal epithelial cells; Mast, mast cells; M, melanoma; MC, mesothelioma cells; mov, immortalized Schwann cells; P, platelets; Ret, reticulocytes; T, T cells; and U, urine.
  • Figure S1: Enhanced T-cell activation by mature exosomes is not due to contaminants (JPG, 34.2 KB) -

    [3H]-thymidine incorporation by Marilyn T cells cultured with mature BMDCs and mature exosomes (Mat HY Exo) or immature exosomes (Imm HY Exo) in the presence of increasing doses of LPS (0, 10 or 100 ng/mL). One representative of 3 independent experiments is shown. The amount of residual LPS in mature exosome preparations was quantified, by limulus amoebocyte assay, as 1.5 ng exosomes per microgram in 2 independent preparations. Thus, at most, 1.5 ng LPS would be added together with mature exosomes in the 150-µL volume of antigen presentation assay, amounting to 10 ng/mL LPS. This quantity is 100 times lower than the amount needed to induce BMDC maturation (i.e. above 1 µg/mL).

  • Figure S2: Enhanced in vivo activity of mature exosomes is not due to LPS (JPG, 29.4 KB) -

    5 µg exosomes was injected subcutaneously into female C57Bl/6 mice containing adoptively transferred, CFSE-labeled CD45.1+ Marilyn lymph-node cells. Draining lymph-node cells were analyzed by FACS 4 days after injection. The percentage of cells that underwent more than 5 divisions cycles (A), and the number of Marilyn T cells in the draining lymph nodes (B), in mice treated with HY-bearing immature exosomes (clear), HY-bearing immature exosomes + 50 ng LPS (grey) or HY-bearing mature exosomes (black), are shown (3 mice per group). Results are taken from one representative of 3 independent experiments.

  • Figure S3: specific MHC-peptide complexes are only slightly increased on mature exosomes (JPG, 85.1 KB) -

    The amount of MHC II–peptide complexes on immature (imm exo) and mature (mat exo) exosomes was quantified by FACS analysis of exosome-coated beads using Y-Ae antibody, which recognizes I-Ab-IE56-73 complexes. 5 µg immature or mature exosomes from D1 cells pulsed with the IE peptide were coated on beads and stained with anti-I-Ab (MHC II), Y-Ae, anti-CD86, and anti-ICAM-1 antibodies. Grey histograms indicate isotype control; bold histograms, specific staining; numbers, the mean fluorescence index. I-Ab is increased 2 times and I-Ab-E is increased 1.5 times in mature exosomes compared with immature exosomes. One representative experiment of 3 is shown.

  • Figure S4: ICAM-1 is essential to exosome-mediated T cell activation by B cells (JPG, 37.9 KB) -

    [3H]-thymidine incorporation by Marilyn T cells cultured with splenic B cells and HY-bearing mature exosomes from WT (Mat WT Exo) or ICAM-1–/– (Mat ICAM–/– Exo) BMDCs. One representative of 2 independent experiments is shown.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020